B.Shield has denied CPT 30117 as Experimental/Investigational. Has anyone successfully appealed and gotten paid? Is there a better code I should be looking at?
X returns to our office today for removal of internal nasal lesion. (Please refer to dictation from XX/XX/XXXX for complete historical details.) After reviewing the informed consent conference in detail (reviewing risks benefits, alternatives and prognosis, and pre- and post-care instructions), X indicated understanding of the above discussion and expressed to proceed with the procedure.
Under direct and endoscopic visualization, the left nasal cavity was first anesthetized with 0.5 mL of 2% lidocaine with 0.5% Neo-Synephrine solution. The 25-gauge needle was then utilized to inject 1.5 mL of 2% lidocaine with 1:100,000 epinephrine directly into the anterior portion of the left inferior turbinate. Under microscopic visualization, a linear incision was made in the anterior portion of the inferior turbinate, and dissection proceeded through the submucosal turbinate tissues, removing the lesion in its entirety, which was placed in formalin and sent off for histopathology. Hemostasis was achieved with the handheld cautery, along with topical silver nitrate. A light application os Surgicel packing was then applied. X tolerated the procedure well. Estimated blood loss less than 3 mm. Specimens include anterior turbinate lesion sent off for histopathology. Post-care instructions have been reviewed in detail with X, with follow-up planned in 10-14 days. X indicated understanding of the post-procedure management plan.
X returns to our office today for removal of internal nasal lesion. (Please refer to dictation from XX/XX/XXXX for complete historical details.) After reviewing the informed consent conference in detail (reviewing risks benefits, alternatives and prognosis, and pre- and post-care instructions), X indicated understanding of the above discussion and expressed to proceed with the procedure.
Under direct and endoscopic visualization, the left nasal cavity was first anesthetized with 0.5 mL of 2% lidocaine with 0.5% Neo-Synephrine solution. The 25-gauge needle was then utilized to inject 1.5 mL of 2% lidocaine with 1:100,000 epinephrine directly into the anterior portion of the left inferior turbinate. Under microscopic visualization, a linear incision was made in the anterior portion of the inferior turbinate, and dissection proceeded through the submucosal turbinate tissues, removing the lesion in its entirety, which was placed in formalin and sent off for histopathology. Hemostasis was achieved with the handheld cautery, along with topical silver nitrate. A light application os Surgicel packing was then applied. X tolerated the procedure well. Estimated blood loss less than 3 mm. Specimens include anterior turbinate lesion sent off for histopathology. Post-care instructions have been reviewed in detail with X, with follow-up planned in 10-14 days. X indicated understanding of the post-procedure management plan.